Gene expression analysis of urethane-induced lung tumors in rasH2 mice

Toxicology

Volumn 217, Issue 2-3, 2006, Pages 129-138

  Okamura, Miwa ^a   Unami, Akira ^b   Matsumoto, Masahiro ^b   Oishi, Yuji ^b   Kashida, Yoko ^a   Mitsumori, Kunitoshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Carcinogenesis; Lung; Microarray; Ras gene; rasH2 mice; Urethane

Indexed keywords

RAS PROTEIN; URETHAN;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CYCLE; DNA MICROARRAY; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ANALYSIS; LUNG TUMOR; MALE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; UPREGULATION;

ADENOMA; ANIMALS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; INJECTIONS, INTRAPERITONEAL; LUNG NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; URETHANE;

ANIMALIA; MUS MUSCULUS;

EID: 28844431503     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2005.09.021     Document Type: Article

References (29)

1. A.G. Casson, S.M. Wilson, J.A. MacCart, F.P. O'Malley, H. Ozcelik, M.S. Tsao, and A.F. Chambers ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer Int. J. Cancer 72 1997 739 745
2. S.T. Doi, M. Kimura, and M. Katsuki Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice Jpn. J. Cancer Res. 85 1994 801 807
3. J. Feng, F. Hua, R. Shuo, G. Chongfeng, X. Huimian, T. Nakajima, W. Subao, and N. Tsuchida Upregulation of non-mutated H-ras and its upstream and downstream signaling proteins in colorectal cancer Oncol. Rep. 8 2001 1409 1413
4. U.J. Gohring, T. Schondorf, V.R. Kiecker, M. Becker, C. Kurbacher, and A. Scharl Immunohistochemical detection of H-ras protooncoprotein p21 indicates favorable prognosis in node-negative breast cancer patients Tumour Biol. 20 1999 173 183
5. X. Guo, Y.P. Zhang, D.A. Mitchell, D.T. Denhardt, and A.F. Chambers Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative EST-related transcription factor whose activity correlates with the metastasis potential of the cell Mol. Cell Biol. 15 1995 476 487
6. N. Inui, K. Kitagawa, S. Miwa, T. Hattori, K. Chida, H. Nakamura, and M. Kitagawa High expression of Cks1 in human non-small cell lung carcinomas Biochem. Biophys. Res. Commun. 303 2003 978 984
7. R. Kawano, T. Nishisaka, Y. Takeshima, S. Yonehara, and K. Inai Role of point mutation of the K-ras gene in tumorigenesis of B6C3F1 mouse lung lesions induced by urethane Jpn. J. Cancer Res. 86 1995 802 810
8. H. Kiaris, D.A. Spandidos, A.S. Jone, E.D. Vaughan, and J.K. Field Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck Br. J. Cancer 72 1995 123 128
9. S. Kitajima, Y. Kudo, I. Ogawa, T. Bashir, M. Kitagawa, M. Miyauchi, M. Pagano, and T. Takata Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation Am. J. Pathol. 165 2004 2147 2155
10. L. Klampfer, J. Huang, T. Sasazuki, S. Shirasawa, and L. Augenlicht Oncogenic Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression J. Biol. Chem. 279 2004 36680 36688
11. R.R. Maronpot, K. Mitsumori, P. Mann, M. Takaoka, S. Yamamoto, T. Usui, H. Okamiya, S. Nishikawa, and T. Nomura Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model Toxicology 146 2000 149 159
12. C. Maruyama, M. Tomisawa, S. Wakana, H. Yamazaki, H. Kijima, H. Suemizu, Y. Ohnishi, Y. Urano, K. Hioki, T. Usui, M. Nakayama, T. Tsuchida, K. Mitsumori, T. Nomura, N. Tamaoki, and Y. Ueyama Overexpression of human H-ras transgene is responsible for tumors induced by chemical carcinogens in mice Oncol. Rep. 8 2001 233 237
13. J.S. MacDonald, K.M. Wilson, P. Gartside, R.L. Sonke, L. Pavelic, E. Okum, J. Neanen, J.L. Gluckman, and Z.P. Pavelic Immunohistochemical expression of N-ras oncogene is a late event in head and neck carcinomas Pathol. Oncol. Res. 2 1996 30 33
14. K. Mitsumori, S. Wakana, S. Yamamoto, Y. Kodama, K. Yasuhara, T. Nomura, Y. Hayashi, and R.R. Maronpot Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors Mol. Carcinog. 20 1997 298 307
15. K. Mitsumori, K. Yasuhara, I. Mori, S. Hayashi, T. Shimo, H. Onodera, T. Nomura, and Y. Hayashi Pulmonary fibrosis caused by N-methyl-N-nitrosourethane inhibits lung tumorigenesis by urethane in transgenic mice carrying the human prototype c-Ha-ras gene Cancer Lett. 129 1998 181 190
16. I. Mori, K. Yasuhara, S.M. Hayashi, T. Nonoyama, T. Nomura, and K. Mitsumori Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene Cancer Lett. 153 2000 199 209
17. I. Mori, K. Yasuhara, S.M. Hayashi, T. Nonoyama, T. Nomura, T. Yanai, T. Masegi, and K. Mitsumori Aberrant expression of cyclin D1 in pulmonary proliferative lesions induced by high doses of urethane in transgenic mice carrying the human prototype c-H-ras gene Vet. Med. Sci. 63 2001 261 268
18. M. Noda, J. Oh, R. Takahashi, S. Kondo, H. Kitayama, and C. Takahashi RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling Cancer Metastasis Rev. 22 2003 167 175
19. M. Ozaki, K. Ozaki, T. Watanabe, S. Uwagawa, Y. Okuno, and T. Shirai Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains Toxicol. Pathol. 33 2005 267 271
20. M. Okamura, K. Sumida, T. Muto, Y. Kashida, N. Machida, T. Watanabe, and K. Mitsumori Analysis of gene expression profiles of forestomach tumors in rasH2 mice initiated with N-ethyl-N-nitrosourea Arch. Toxicol. 78 2004 688 696
21. N. Sagawa, H. Fujita, Y. Banno, Y. Nozawa, H. Katoh, and N. Kuzumaki Gelsolin suppresses tumorigenicity through inhibiting PCK activation in a human lung cancer cell line PC10 Br. J. Cancer 88 2003 606 612
22. V. Shah, R. Braverman, and G.L. Prasad Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins Somat. Cell Mol. Genet. 24 1998 573 580
23. N. Tamaoki The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis Toxicol. Pathol. 29 Suppl. 2001 81 89
24. M. Tomisawa, H. Suemizu, Y. Ohnishi, C. Maruyama, K. Urano, T. Usui, K. Yasuhara, N. Tamaoki, and K. Mitsumori Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice Toxicol. Lett. 142 2003 111 117
25. T. Usui, M. Mutai, S. Hisada, S. Takaoka, K.A. Soper, B. McCullough, and C. Alden CB6F1-rasH2 mouse: overview of available data Toxicol. Pathol. 29 Suppl. 2001 90 108
26. S. Vasseur, C. Malicet, E.L. Calvo, C. Labrie, P. Berthezene, J.C. Dagorn, and J.L. Iovanna Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene Mol. Cancer 19 2003 19
27. P.Y. Wai, and P.C. Kuo The role of osteopontin in tumor metastasis J. Surg. Res. 121 2004 228 241
28. Y. Wu, D.T. Denhardt, and S.R. Rittling Osteopontin is required for full expression of the transformed phenotype by the ras oncogene Br. J. Cancer 83 2000 156 163
29. S. Yamamoto, K. Mitsumori, Y. Kodama, N. Matsunuma, S. Manabe, H. Okamiya, H. Suzuki, T. Fukuda, Y. Sakamaki, M. Sunaga, G. Nomura, K. Hioki, S. Wakana, T. Nomura, and Y. Hayashi Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice Carcinogenesis 17 1996 2455 2461